Orofacial quantitative sensory testing: Current evidence and future perspectives

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

DOI

  • Fréderic Van der Cruyssen, University Hospitals Leuven, University of Leuven, Belgien
  • Loes Van Tieghem, University Hospitals Leuven, Belgien
  • Tomas-Marijn Croonenborghs, University Hospitals Leuven, University of Leuven, Belgien
  • Lene Baad-Hansen
  • Peter Svensson
  • Tara Renton, Department of Oral Surgery, King's College London Dental Institute, London, UK., Storbritannien
  • Reinhilde Jacobs, Department of Dental Medicine, Karolinska Institutet, University of Leuven
  • ,
  • Constantinus Politis, University Hospitals Leuven, University of Leuven
  • ,
  • Antoon De Laat, University Hospitals Leuven, Belgien

BACKGROUND AND OBJECTIVE: Orofacial quantitative sensory testing (QST) is an increasingly valuable psychophysical tool for evaluating neurosensory disorders of the orofacial region. Here, we aimed to evaluate the current evidence regarding this testing method and to discuss its future clinical potential.

DATA TREATMENT: We conducted a literature search in Medline, Embase and Scopus for English-language articles published between 1990 and 2019. The utilized search terms included QST, quantitative, sensory testing and neurosensory, which were combined using the AND operator with the terms facial, orofacial, trigeminal, intraoral and oral.

RESULTS: Our findings highlighted many methods for conducting QST-including method of levels, method of limits and mapping. Potential stimuli also vary, and can include mechanical or thermal stimulation, vibration or pinprick stimuli. Orofacial QST may be helpful in revealing disease pathways and can be used for patient stratification to validate the use of neurosensory profile-specific treatment options. QST is reportedly reliable in longitudinal studies and is thus a candidate for measuring changes over time. One disadvantage of QST is the substantial time required; however, further methodological refinements and the combination of partial aspects of the full QST battery with other tests and imaging methods should result in improvement.

CONCLUSIONS: Overall, orofacial QST is a reliable testing method for diagnosing pathological neurosensory conditions and assessing normal neurosensory function. Despite the remaining challenges that hinder the use of QST for everyday clinical decisions and clinical trials, we expect that future improvements will allow its implementation in routine practice.

OriginalsprogEngelsk
TidsskriftEuropean journal of pain (London, England)
Vol/bind24
Nummer8
Sider (fra-til)1425-1439
Antal sider15
ISSN1090-3801
DOI
StatusUdgivet - sep. 2020

Bibliografisk note

© 2020 The Authors. European Journal of Pain published by John Wiley & Sons Ltd on behalf of European Pain Federation EFIC ®.

Se relationer på Aarhus Universitet Citationsformater

ID: 192427533